Profile
Lies Vanneste is currently the Director-Investor Relations at Sequana Medical NV since 2018.
Prior to this, Vanneste worked as the Director-Investor Relations at Ablynx NV.
Lies Vanneste active positions
| Companies | Position | Start |
|---|---|---|
| SEQUANA MEDICAL N.V. | Investor Relations Contact | 2018-06-30 |
Former positions of Lies Vanneste
| Companies | Position | End |
|---|---|---|
| ABLYNX | Investor Relations Contact | 2018-05-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SEQUANA MEDICAL N.V. | Health Technology |
| Private companies | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Stock Market
- Insiders
- Lies Vanneste
